Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 32.1% in May

Terumo Corp. (OTCMKTS:TRUMY) saw a large decline in short interest in May. As of May 31st, there was short interest totalling 20,500 shares, a decline of 32.1% from the May 15th total of 30,200 shares. Based on an average daily trading volume, of 210,100 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are sold short.

Terumo Trading Up 1.5%

Shares of Terumo stock opened at $17.97 on Thursday. Terumo has a fifty-two week low of $14.06 and a fifty-two week high of $21.22. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.78 and a current ratio of 3.00. The company has a market capitalization of $26.61 billion, a P/E ratio of 34.56 and a beta of 0.80. The company has a fifty day moving average of $18.75 and a 200 day moving average of $18.83.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings data on Wednesday, May 14th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.07). Terumo had a net margin of 11.28% and a return on equity of 8.48%. The business had revenue of $1.79 billion during the quarter, compared to analysts’ expectations of $1.79 billion.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.